Elsevier

European Journal of Cancer

Volume 31, Issue 12, November 1995, Pages 1998-2002
European Journal of Cancer

Original paper
Analysis of P-glycoprotein expression in osteosarcoma

https://doi.org/10.1016/0959-8049(95)00335-5Get rights and content

Abstract

Current treatment of high-grade osteosarcoma combines surgical removal of the lesion with chemotherapy. In this study we evaluated whether the expression of P-glycoprotein, a protein closely associated with multidrug resistance, may be helpful in identifying the patients whose tumours will be further resistant to specific agents. By using multidrug-resistant osteosarcoma cell lines as standards, the expression of P-glycoprotein was evaluated in 105 cases of primary and metastatic osteosarcoma by semiquantitative immunofluorescence. Overexpression of the protein was shown in 23% of primary and in 50% of metastatic lesions. In 38 cases, homogeneously treated and followed-up for at least 24 months, overexpression of P-glycoprotein appeared to be associated with a higher relapse rate and with a trend toward a worse outcome. These data support the role of P-glycoprotein in the response to chemotherapy and its involvement in the determination of the outcome of osteosarcoma patients.

References (24)

  • AT Fojo et al.

    Expression of a multidrug-resistance gene in human tumors and tissues

  • HSL Chan et al.

    Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood

    J Clin Oncol

    (1990)
  • Cited by (47)

    • Genomic and proteomic profiling of osteosarcoma

      2021, Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
    • Role of ATP-binding cassette transporters in cancer initiation and progression

      2020, Seminars in Cancer Biology
      Citation Excerpt :

      Some of these studies also include information on associations between P-gp expression and tumor characteristics. P-gp expression evaluated in 105 cases of primary and metastatic osteosarcoma was detected in 23% of primary and in 50% of metastatic lesions [200]. Increased P-gp levels were observed in 44% of the patients with osteosarcoma before treatment, particularly in those with tumors greater than or equal to 10 cm in size (60%) or with tumors associated with metastatic disease (100%) [201].

    • ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells

      2019, Cancer Letters
      Citation Excerpt :

      One mechanism of acquired MDR is the overexpression of ABC transporter proteins, such as p-glycoprotein (Pgp, ABCB1), which induce MDR through the active efflux of chemotherapeutic agents from cells to reduce the efficacy of the treatment and enabling cell survival. In OST, high expression of Pgp has been linked with a worse disease progression [15–18]. Cells with an aggressive MDR metastatic phenotype have been described in a variety of cancers [19–25], including OST [26–29] and are often referred to as cancer stem-like cells (CSCs).

    • Gene and proteomic profiling of osteosarcoma

      2015, Bone Cancer: Primary Bone Cancers and Bone Metastases: Second Edition
    • Prognostic factors in localized extremity osteosarcoma: A systematic review

      2009, European Journal of Surgical Oncology
      Citation Excerpt :

      The newly reported factors are mostly “indirect” factors, like protein expression in serum or genetic imbalances of tumor tissue. Most promising among these seem to be the high expression of p-glycoprotein,11,42–47 expression of the human epidermal growth factor receptor 2 (HER2),10,48–51 expression of vascular endothelial growth factor (VEGF),38,52–54 and loss of heterogeneity of the Rb-gene.55 It is possible that some of these factors may be of true predictive value, but it is important to keep in mind that the majority of these studies had methodological flaws.

    • Proteins expressed in osteosarcoma and serum levels as prognostic factors

      2001, International Journal of Biochemistry and Cell Biology
    View all citing articles on Scopus
    View full text